Trimethoprim-Sulfamethoxazole vs Ampicillin in Chronic Urinary Tract Infections
- 4 August 1975
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 233 (5) , 427-431
- https://doi.org/10.1001/jama.1975.03260050033016
Abstract
A multicenter, prospective, double-blind, controlled study was performed to compare the efficacy of trimethoprim-sulfamethoxazole with that of ampicillin in the treatment of chronic urinary tract infections. The incidence of adverse clinical signs and symptoms as well as abnormal laboratory values were comparable in the two treatment groups. This study appears to establish the fact that trimethoprim-sulfamethoxazole is an acceptable alternative to ampicillin for the treatment of chronic urinary tract infections caused by susceptibleEscherichia coli. (JAMA233:427-431, 1975)Keywords
This publication has 5 references indexed in Scilit:
- A Cooperative Controlled Study of the Use of Trimethoprim-Sulfamethoxazole in Chronic Urinary Tract InfectionsThe Journal of Infectious Diseases, 1973
- Double-blind Trial to Compare Ampicillin, Cephalexin, Co-trimoxazole, and Trimethoprim in Treatment of Urinary InfectionBMJ, 1972
- DOUBLE‐BLIND TRIAL COMPARING TRIMETHOPRIM‐SULPHAMETHOXAZOLE (BACTRIM) WITH AMPICILLIN IN TREATING URINARY INFECTIONSThe Medical Journal of Australia, 1972
- Treatment of PyelonephritisNew England Journal of Medicine, 1965
- Factors Determining the Outcome of Chemotherapy in Infections of the Urinary TractAnnals of Internal Medicine, 1963